Drug intelligence / Profile preview

aminophylline + hydrocortisone + salbutamol

Development stage
Unknown
Lead developer
Memphitis
Modality
Small Molecules
Administration
Intravenous, Inhalation
01

Overview

A combination therapy used for the treatment of acute asthma exacerbations. It consists of three medications with different mechanisms of action: 1. **Aminophylline**: A bronchodilator containing theophylline that relaxes smooth muscles in the bronchi and stimulates the CNS, skeletal muscles, and cardiac muscle. 2. **Hydrocortisone**: A corticosteroid that reduces inflammation in the airways. 3. **Salbutamol (Albuterol)**: A short-acting beta-2 agonist that relieves bronchospasm by relaxing airway smooth muscle. Research suggests that while this combination is commonly used, intravenous aminophylline may add to the toxicity but not significantly improve the efficacy when combined with high doses of inhaled salbutamol and hydrocortisone in treating acute asthma exacerbations.

02

Targets

GR (Glucocorticoid receptor)PDE3/4 (Phosphodiesterase 3/4)ADRB2 (β2)

Beyond the preview

Go deeper on aminophylline + hydrocortisone + salbutamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aminophylline + hydrocortisone + salbutamol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call